Abstract
Atherosclerosis is a disease of the large and middle arteries and is characterized mainly by endothelial dysfunction, inflammation of the vascular wall and the accumulation of lipids, cholesterol, calcium and cell debris in the intima of the vascular wall. This accumulation leads to plaque formation, vascular remodeling, acute and chronic obstruction of the vessel lumen, blood flow abnormalities, and reduced oxygen supply to target organs. As a result, blood vessels become harder and their lumen shrinks, which increases the risk of obstruction and thrombosis. Depending on the affected area, the corresponding symptoms appear - angina or myocardial infarction when affecting the coronary circulation; transient ischemic attack (TIA) or stroke affecting cerebral circulation; claudication or gangrene when affecting the limbs; aneurysm or dissection affecting the aorta. Various risk factors are known to affect the onset of the disease. They are divided into adjustable (dyslipoproteinemia, hypertension, diabetes mellitus, smoking, obesity, inactivity, emotional stress, etc.) and unadjustable (gender, age, family predisposition). The risk of developing atherosclerosis increases significantly in the presence of several risk factors. For example, the presence of 2 risk factors increases the risk of developing atherosclerosis 4 times.
The atherosclerotic process is multifocal - it develops everywhere in the body - affecting the cardiac, cerebral and peripheral arteries almost simultaneously or sequentially. Its isolated manifestations in only one area are an exception.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Not registered as a clinical trial.
Funding Statement
No external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The approval was given by the ethics committee of Heart and Brain, Center of Excellence, Pleven, Bulgaria. The members are associate professor Iana Simova, professor Nikolay Dimitrov, professor Toni Vekov. Their institutions are Bulgarian Cardiac Institute and Heart and Brain, Center of Excellence, Pleven, Bulgaria.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is available online.
